CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 246 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $569,771 | -14.2% | 48,740 | -1.4% | 0.37% | -4.4% |
| Q2 2023 | $664,339 | -39.3% | 49,430 | -25.1% | 0.38% | -34.2% |
| Q1 2023 | $1,094,844 | -11.1% | 66,034 | -0.2% | 0.58% | +3.4% |
| Q4 2022 | $1,230,892 | +5.6% | 66,177 | -27.2% | 0.57% | -6.4% |
| Q3 2022 | $1,166,000 | +83.0% | 90,864 | 0.0% | 0.60% | +94.5% |
| Q2 2022 | $637,000 | -15.4% | 90,864 | 0.0% | 0.31% | +0.6% |
| Q1 2022 | $753,000 | – | 90,864 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |